
1. Technology overview
Percisio SAS is a company based at 24 rue du Faubourg Saint-Jacques, Paris, France. It builds AI-powered vision systems for real-time precision navigation in medical procedures, aimed at interventional teams that currently rely on repeated imaging to guide needles and instruments.
The system turns CT, MRI and ultrasound data into holographic guidance for the clinician. The product family consists of Percisio Navigation, Percisio Sense and Percisio Insight. The company reports a mean guidance error of 2 mm or less on needle trajectory, measured on a test bench or phantom, and under 3 minutes from power-on to complete calibration.
2. Highlighted features & specifications
- Percisio Navigation: holographic guidance built from CT, MRI and ultrasound data.
- Percisio Sense: sensing component of the product family.
- Percisio Insight: analysis component of the product family.
- Needle guidance: stereotactic needle trajectory guidance described in a 2026 blog post.
- Fast calibration: under 3 minutes from power-on to complete calibration.
- Learn mode: a training mode described in a September 2026 blog post.
3. Potential application
Interventional radiology units can use guided needle placement for biopsies and ablations. Teaching hospitals can use the training mode for resident education. Ultrasound-guided pain and anaesthesia procedures are another candidate use.
4. Benefits
The company reports 40 percent fewer control images, which lowers radiation exposure. Calibration takes under 3 minutes from power-on in the observed workflow. Guidance error is stated at 2 mm or less on a bench or phantom, not in patients. The page also claims procedure times cut by up to 40 percent.
5. Market trends & opportunities
Interventional radiology and image-guided biopsy are growing, and hospitals look for ways to cut radiation dose and procedure time. Vietnamese tertiary hospitals investing in minimally invasive cancer diagnosis may seek navigation aids that work with existing CT and ultrasound equipment.
6. Other information
Percisio SAS, Paris, France. Selected for incubation at Paris Biotech Santé in March 2026. Partners and supporters listed include AP-HP, Bpifrance, Medicen Paris Region and Google for Startups. Finalist in the MEDICA Start-up Competition listing.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































